重组Anti SARS-CoV-2 Spike Glycoprotein S1 [Omi2-18] BSA and Azide Free
Anti SARS-CoV-2 Spike Glycoprotein S1 [Omi2-18] BSA and Azide Free
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(0 Publication)
Human Recombinant Monoclonal SPIKE antibody. Carrier free. Suitable for I-ELISA and reacts with SARS-CoV-2 samples.
查看别名
2, S, Spike glycoprotein, S glycoprotein, E2, Peplomer protein
- I-ELISA
Supplier Data
Indirect ELISA - Anti SARS-CoV-2 Spike Glycoprotein S1 [Omi2-18] BSA and Azide Free (AB320075)
Indirect ELISA- Anti SARS-CoV-2 Spike Glycoprotein S1 [Omi2-18] Antibody (ab320075). Indirect ELISA showing primary antibody ab320075 binding to Recombinant SARS-CoV-2 Spike Trimer, His Tag, (B.1.1.529/Omicron) and SARS-CoV-2 Spike RBD, His Tag, (B.1.1.529/Omicron). Plates were coated with Recombinant SARS-CoV-2 Spike Trimer, His Tag, (B.1.1.529/Omicron), SARS-CoV-2 Spike RBD, His Tag, (B.1.1.529/Omicron) and Recombinant Human Coronavirus SARS-CoV-2 Spike Glycoprotein RBD (His tag), ab275986, (2019-nCoV, SARS-CoV-2) at 1000 ng/ml. Binding of ab320075 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution).
不同偶联物与剂型 (1)
-
Anti SARS-CoV-2 Spike Glycoprotein S1 [Omi2-18]
反应性数据
产品详情
ab320075 is the carrier-free version of ab320074.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The SARS-CoV-2 Spike Glycoprotein initiates viral entry by interacting with the host cell's ACE2 receptor which leads to viral fusion and entry into the cell's cytoplasm. The protein is part of the virion structure and forms the visible spike on the virion's surface. Upon binding a conformational change triggers the fusion of viral and cellular membranes a vital step for the viral lifecycle. The multimeric nature of the Spike Protein facilitates its interaction with antibodies including those known as 'anti-spike antibodies' which can neutralize the virus and prevent cell infection.
Pathways
The Spike Glycoprotein plays a significant role in the viral infection process and immune response pathways. It is central to the receptor-mediated endocytosis pathway where the virus is internalized into host cells. The protein’s interaction with ACE2 modifies downstream signaling pathways potentially altering host cell functions. Related proteins in these pathways include the ACE2 receptor and the cellular protease TMPRSS2 which primes the Spike Protein for fusion and viral entry.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com